Craig Earle

Overview

The purpose of the OICR Health Services Research Program is to enhance Ontario’s capacity to study the organization and delivery of cancer services across the province. The program aims to improve the quality and availability of new data about Ontario's health care system, to attract qualified researchers to Ontario, and to facilitate new studies addressing access, quality, cost, and outcomes of cancer care. The Health Services Research Program aims to inform health policies, optimize the delivery of cancer care and maximize the benefits of the province's cancer research for those currently living with the disease.

Contact Information

Dr. Craig Earle

craig [dot] earleatices [dot] on [dot] ca

Telephone: 416-673-8589

Affiliations

2008 - Program Director, Health Services Research, Ontario Institute for Cancer Research (OICR).
2007 - 2008Director, Perini Adult Survivorship Program, Dana-Farber Cancer Institute.
1998M.Sc., Epidemiology, University of Ottawa.
1996Fellow of The Royal College of Physicians of Canada (FRCPC), Medical Oncology, University of Ottawa.
1990MD, University of Ottawa.

Research Output

  • Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, Trimble EL, Bodurka DC, Bristow RE, Carney M, and Warren JL
    Effect of surgeon specialty on processes and outcomes for ovarian cancer
    • J Natl Cancer Inst. 2006;98(3):172-80
  • Earle CC, Neville BA
    Underuse of necessary care among cancer survivors
    • Cancer. 2004;101(8):1712-9
  • Earle CC, Neville BA, Landrum ME, Ayanian JZ, Block SD, Weeks JC
    Trends in the aggressiveness of cancer care near the end of life
    • J Clin Oncol. 2004;22(2):315-21
  • Earle CC, Nattinger AB, Potosky AL, Lang K, Mallick R, Berger M, Warren JL
    Identifying cancer relapse using SEER-Medicare data
    • Medical Care. 2002; 40(8s):75-82
  • Earle CC, Tsai JS, Gelber RD, Neumann PJ, Weinstein MC, Weeks JC
    Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis
    • J Clin Oncol. 2000;19:1064-70